Shah Preetam (CIK 1787403) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Buy ELTX (24,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | Elicio Therapeutics, Inc. (ELTX) | Chief Strategy and Financial Officer | Buy | 24,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-02-03